News in brief: Cann completes NAB settlement; Bioxyne releases GMP-certified MDMA capsules by Adam Sheldon November 11, 2025February 21, 2026 Cann Group has completed its refinancing agreement with National Australia Bank (NAB), marking the conclusion of […]
Breathe Life Sciences launches Curaleaf medical inhalation device by Adam Sheldon November 3, 2025November 3, 2025
Record revenue for Bioxyne but cash deficit rises after flower investment by Steve Jones October 30, 2025November 3, 2025
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
‘It’s super exciting’ – Breathe Life Sciences secures ARTG listings for Dr Watson range by Adam Sheldon October 9, 2025October 13, 2025
Trump CBD video sparks US stock rally – and hope among local firms by Adam Sheldon October 1, 2025October 1, 2025
News in brief: Epsilon receives EU, UK GMP certificates; AGH raises $2.6m via placement; Zelira secures loan notes; Bioxyne’s $5m German order by Steve Jones September 17, 2025February 21, 2026
James Yodgee steps away from ‘brutal’ cultivation sector to join Breathe Life Sciences by Adam Sheldon July 10, 2025July 10, 2025
Bioxyne shares spike after upgrade to FY25 revenue forecast by Adam Sheldon June 12, 2025June 12, 2025
Bioxyne stays on course to hit A$25m revenue guidance despite Q3 fall by Steve Jones April 28, 2025April 28, 2025
